financetom
Business
financetom
/
Business
/
Amazon's Wondery podcast unit trims jobs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon's Wondery podcast unit trims jobs
Feb 28, 2025 11:05 AM

Feb 28 (Reuters) - Amazon ( AMZN ) cut "a small number"

of jobs at its Wondery podcast unit, known for "Dr. Death" and

"Business Wars," the company said in a statement to Reuters on

Friday.

Amazon ( AMZN ) purchased the company in 2020 for a reported $300

million and last year signed a 3-year $100 million deal for

rights to "New Heights with Jason and Travis Kelce," a podcast

featuring the brothers of National Football League fame.

"We regularly review our team structures to ensure we're

best set up to serve customers," said Amazon ( AMZN ) spokesperson Alice

Zou. "Following a recent review, we've identified a small number

of roles in the Wondery organization that are no longer

required."

A person familiar with the matter who spoke to Reuters on

condition of anonymity said both the content and advertising

teams were affected and that it appeared to involve "dozens and

dozens" of workers. Zou said the number was lower without

providing details.

Wondery was founded in 2016 and has produced several

podcasts that were adapted for streaming television, such as

"The Shrink Next Door."

Amazon ( AMZN ) most recently cut jobs among its communications staff

last month in an effort to reduce costs and what CEO Andy Jassy

has called an abundance of bureaucracy.

Jassy has slashed tens of thousands of corporate jobs since

taking the helm in July 2021. Last year he announced a goal to

reorganize business units in order to reduce the ratio of

managers to "individual contributors" by the end of this year's

first quarter.

Amazon ( AMZN ) shares were trading down less than 1% at $208.35.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Medtech Orthofix Medical Q2's sales growth beat expectations
Medtech Orthofix Medical Q2's sales growth beat expectations
Aug 5, 2025
Overview * Orthofix Medical Q2 2025 net sales rise 2.3%, beating analyst expectations, per LSEG data * Adjusted EBITDA for Q2 2025 beats consensus, reflecting operational improvements * Co launched TrueLok Elevate TBT System and Reef L Interbody System Outlook * Orthofix reaffirms full-year 2025 net sales guidance of $808 mln to $816 mln * Company expects 2025 adjusted EBITDA...
Organon beats Q2 revenue expectations, raises FY guidance
Organon beats Q2 revenue expectations, raises FY guidance
Aug 5, 2025
Overview * Organon Q2 revenue of $1.594 bln beats analyst expectations; raises full-year guidance * Adjusted EPS of $1.00 exceeds estimates, indicating strong performance * Company repaid $345 mln of long-term debt Outlook * Organon raises 2025 revenue guidance to $6.275 bln-$6.375 bln * Company affirms 2025 adjusted EBITDA margin guidance at 31%-32% * Organon targets net leverage below 4.0x...
Harmony Biosciences Q2 revenue misses estimates
Harmony Biosciences Q2 revenue misses estimates
Aug 5, 2025
Overview * Harmony Biosciences Q2 2025 revenue grows 16% YoY but misses analyst expectations * Company reaffirms 2025 revenue guidance, maintaining $820-$860 mln target * Harmony on track for Phase 3 ZYN002 trial results in Fragile X syndrome, Q3 2025 Outlook * Harmony reaffirms 2025 revenue guidance of $820 mln to $860 mln * Company on track for Phase 3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved